共 50 条
- [21] HISTOPATHOLOGICAL CHANGES INDUCED BY DAUNOMYCIN (NSC =82151) IN HAMSTER PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1969, 10 (MAR): : 23 - &
- [22] ENHANCEMENT OF ANTITUMOR EFFECTIVENESS OF ICRF-159 (NSC-129943) AGAINST EARLY L1210 LEUKEMIA BY COMBINATION WITH CIS-DIAMMINEDICHLOROPLATINUM (NSC-119875) OR DAUNOMYCIN (NSC-82151) CANCER CHEMOTHERAPY REPORTS PART 2 SUPPLEMENT, 1974, 4 (01): : 45 - 52
- [23] CONTACT-DERMATITIS ASSOCIATED WITH ADRIAMYCIN (NSC-123127) AND DAUNORUBICIN (NSC-82151) CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (04): : 677 - 678
- [24] TOXICOLOGIC SCREENING OF DAUNORUBICIN (NSC-82151), ADRIAMYCIN (NSC-123127), AND THEIR DERIVATIVES IN RATS CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (04): : 707 - 715
- [25] DAUNORUBICIN (NSC-82151), VINCRISTINE (NSC-67574), CYTOSINE-ARABINOSIDE (NSC-63878), AND PREDNISONE (NSC-10023) COMBINATION THERAPY FOR ADVANCED ADULT ACUTE-LEUKEMIA CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (04): : 757 - 760
- [26] COMPARATIVE REDUCTIVE METABOLISM OF DAUNOMYCIN (NSC 82151) AND ADRIAMYCIN (NSC 123, 127) INVITRO PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 86 - 86
- [28] ANOTHER HYPOTHESIS CONCERNING ANTITUMOR ACTIVITY AND CARDIOTOXICITY OF DAUNORUBICIN (NSC-82151) AND ADRIAMYCIN (NSC-123127) CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (02): : 258 - 259
- [29] CELL-INTERACTIONS - DETERMINANTS OF SELECTIVE TOXICITY OF ADRIAMYCIN (NSC-123127) AND DAUNORUBICIN (NSC-82151) CANCER CHEMOTHERAPY REPORTS PART 3 PROGRAM INFORMATION-SUPPLEMENT, 1975, 6 (02): : 107 - 114